CLOV vs VSTM · rev $1.37B vs rev $10.0M
Clover Health Investments Corp (CLOV) versus Verastem Inc (VSTM) — a side-by-side from cached financials, not a winner call.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
Verastem Inc (VSTM) is a biotechnology company listed on US.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
Latest reported VSTM revenue for 2024-12-31 was $10.0M. Net income was -$130.6M. Revenue was up 285.2% from 2022-12-31 to 2024-12-31. VSTM currently screens at market cap $264.3M.
CLOV currently screens at market cap $1.55B. VSTM currently screens at market cap $264.3M.
Not investment advice. Open the CLOV and VSTM stock pages for the full models.
Not investment advice.